Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer
This document updates the colorectal cancer (CRC) screening recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American College of Gastroenterology, the American Gastroenterological Association, and The American Society for Gastrointestinal Endosco...
Uloženo v:
| Vydáno v: | Gastroenterology (New York, N.Y. 1943) Ročník 153; číslo 1; s. 307 |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.07.2017
|
| Témata: | |
| ISSN: | 1528-0012, 1528-0012 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | This document updates the colorectal cancer (CRC) screening recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American College of Gastroenterology, the American Gastroenterological Association, and The American Society for Gastrointestinal Endoscopy. CRC screening tests are ranked in 3 tiers based on performance features, costs, and practical considerations. The first-tier tests are colonoscopy every 10 years and annual fecal immunochemical test (FIT). Colonoscopy and FIT are recommended as the cornerstones of screening regardless of how screening is offered. Thus, in a sequential approach based on colonoscopy offered first, FIT should be offered to patients who decline colonoscopy. Colonoscopy and FIT are recommended as tests of choice when multiple options are presented as alternatives. A risk-stratified approach is also appropriate, with FIT screening in populations with an estimated low prevalence of advanced neoplasia and colonoscopy screening in high prevalence populations. The second-tier tests include CT colonography every 5 years, the FIT-fecal DNA test every 3 years, and flexible sigmoidoscopy every 5 to 10 years. These tests are appropriate screening tests, but each has disadvantages relative to the tier 1 tests. Because of limited evidence and current obstacles to use, capsule colonoscopy every 5 years is a third-tier test. We suggest that the Septin9 serum assay (Epigenomics, Seattle, Wash) not be used for screening. Screening should begin at age 50 years in average-risk persons, except in African Americans in whom limited evidence supports screening at 45 years. CRC incidence is rising in persons under age 50, and thorough diagnostic evaluation of young persons with suspected colorectal bleeding is recommended. Discontinuation of screening should be considered when persons up to date with screening, who have prior negative screening (particularly colonoscopy), reach age 75 or have <10 years of life expectancy. Persons without prior screening should be considered for screening up to age 85, depending on age and comorbidities. Persons with a family history of CRC or a documented advanced adenoma in a first-degree relative age <60 years or 2 first-degree relatives with these findings at any age are recommended to undergo screening by colonoscopy every 5 years, beginning 10 years before the age at diagnosis of the youngest affected relative or age 40, whichever is earlier. Persons with a single first-degree relative diagnosed at ≥60 years with CRC or an advanced adenoma can be offered average-risk screening options beginning at age 40 years. |
|---|---|
| AbstractList | This document updates the colorectal cancer (CRC) screening recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American College of Gastroenterology, the American Gastroenterological Association, and The American Society for Gastrointestinal Endoscopy. CRC screening tests are ranked in 3 tiers based on performance features, costs, and practical considerations. The first-tier tests are colonoscopy every 10 years and annual fecal immunochemical test (FIT). Colonoscopy and FIT are recommended as the cornerstones of screening regardless of how screening is offered. Thus, in a sequential approach based on colonoscopy offered first, FIT should be offered to patients who decline colonoscopy. Colonoscopy and FIT are recommended as tests of choice when multiple options are presented as alternatives. A risk-stratified approach is also appropriate, with FIT screening in populations with an estimated low prevalence of advanced neoplasia and colonoscopy screening in high prevalence populations. The second-tier tests include CT colonography every 5 years, the FIT-fecal DNA test every 3 years, and flexible sigmoidoscopy every 5 to 10 years. These tests are appropriate screening tests, but each has disadvantages relative to the tier 1 tests. Because of limited evidence and current obstacles to use, capsule colonoscopy every 5 years is a third-tier test. We suggest that the Septin9 serum assay (Epigenomics, Seattle, Wash) not be used for screening. Screening should begin at age 50 years in average-risk persons, except in African Americans in whom limited evidence supports screening at 45 years. CRC incidence is rising in persons under age 50, and thorough diagnostic evaluation of young persons with suspected colorectal bleeding is recommended. Discontinuation of screening should be considered when persons up to date with screening, who have prior negative screening (particularly colonoscopy), reach age 75 or have <10 years of life expectancy. Persons without prior screening should be considered for screening up to age 85, depending on age and comorbidities. Persons with a family history of CRC or a documented advanced adenoma in a first-degree relative age <60 years or 2 first-degree relatives with these findings at any age are recommended to undergo screening by colonoscopy every 5 years, beginning 10 years before the age at diagnosis of the youngest affected relative or age 40, whichever is earlier. Persons with a single first-degree relative diagnosed at ≥60 years with CRC or an advanced adenoma can be offered average-risk screening options beginning at age 40 years. This document updates the colorectal cancer (CRC) screening recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American College of Gastroenterology, the American Gastroenterological Association, and The American Society for Gastrointestinal Endoscopy. CRC screening tests are ranked in 3 tiers based on performance features, costs, and practical considerations. The first-tier tests are colonoscopy every 10 years and annual fecal immunochemical test (FIT). Colonoscopy and FIT are recommended as the cornerstones of screening regardless of how screening is offered. Thus, in a sequential approach based on colonoscopy offered first, FIT should be offered to patients who decline colonoscopy. Colonoscopy and FIT are recommended as tests of choice when multiple options are presented as alternatives. A risk-stratified approach is also appropriate, with FIT screening in populations with an estimated low prevalence of advanced neoplasia and colonoscopy screening in high prevalence populations. The second-tier tests include CT colonography every 5 years, the FIT-fecal DNA test every 3 years, and flexible sigmoidoscopy every 5 to 10 years. These tests are appropriate screening tests, but each has disadvantages relative to the tier 1 tests. Because of limited evidence and current obstacles to use, capsule colonoscopy every 5 years is a third-tier test. We suggest that the Septin9 serum assay (Epigenomics, Seattle, Wash) not be used for screening. Screening should begin at age 50 years in average-risk persons, except in African Americans in whom limited evidence supports screening at 45 years. CRC incidence is rising in persons under age 50, and thorough diagnostic evaluation of young persons with suspected colorectal bleeding is recommended. Discontinuation of screening should be considered when persons up to date with screening, who have prior negative screening (particularly colonoscopy), reach age 75 or have <10 years of life expectancy. Persons without prior screening should be considered for screening up to age 85, depending on age and comorbidities. Persons with a family history of CRC or a documented advanced adenoma in a first-degree relative age <60 years or 2 first-degree relatives with these findings at any age are recommended to undergo screening by colonoscopy every 5 years, beginning 10 years before the age at diagnosis of the youngest affected relative or age 40, whichever is earlier. Persons with a single first-degree relative diagnosed at ≥60 years with CRC or an advanced adenoma can be offered average-risk screening options beginning at age 40 years.This document updates the colorectal cancer (CRC) screening recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American College of Gastroenterology, the American Gastroenterological Association, and The American Society for Gastrointestinal Endoscopy. CRC screening tests are ranked in 3 tiers based on performance features, costs, and practical considerations. The first-tier tests are colonoscopy every 10 years and annual fecal immunochemical test (FIT). Colonoscopy and FIT are recommended as the cornerstones of screening regardless of how screening is offered. Thus, in a sequential approach based on colonoscopy offered first, FIT should be offered to patients who decline colonoscopy. Colonoscopy and FIT are recommended as tests of choice when multiple options are presented as alternatives. A risk-stratified approach is also appropriate, with FIT screening in populations with an estimated low prevalence of advanced neoplasia and colonoscopy screening in high prevalence populations. The second-tier tests include CT colonography every 5 years, the FIT-fecal DNA test every 3 years, and flexible sigmoidoscopy every 5 to 10 years. These tests are appropriate screening tests, but each has disadvantages relative to the tier 1 tests. Because of limited evidence and current obstacles to use, capsule colonoscopy every 5 years is a third-tier test. We suggest that the Septin9 serum assay (Epigenomics, Seattle, Wash) not be used for screening. Screening should begin at age 50 years in average-risk persons, except in African Americans in whom limited evidence supports screening at 45 years. CRC incidence is rising in persons under age 50, and thorough diagnostic evaluation of young persons with suspected colorectal bleeding is recommended. Discontinuation of screening should be considered when persons up to date with screening, who have prior negative screening (particularly colonoscopy), reach age 75 or have <10 years of life expectancy. Persons without prior screening should be considered for screening up to age 85, depending on age and comorbidities. Persons with a family history of CRC or a documented advanced adenoma in a first-degree relative age <60 years or 2 first-degree relatives with these findings at any age are recommended to undergo screening by colonoscopy every 5 years, beginning 10 years before the age at diagnosis of the youngest affected relative or age 40, whichever is earlier. Persons with a single first-degree relative diagnosed at ≥60 years with CRC or an advanced adenoma can be offered average-risk screening options beginning at age 40 years. |
| Author | Dominitz, Jason A Levin, Theodore R Robertson, Douglas J Johnson, David A Rex, Douglas K Giardiello, Francis M Lieberman, David Kaltenbach, Tonya Boland, C Richard |
| Author_xml | – sequence: 1 givenname: Douglas K surname: Rex fullname: Rex, Douglas K email: drex@iu.edu organization: Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: drex@iu.edu – sequence: 2 givenname: C Richard surname: Boland fullname: Boland, C Richard organization: University of California San Diego, San Diego, California – sequence: 3 givenname: Jason A surname: Dominitz fullname: Dominitz, Jason A organization: VA Puget Sound Health Care System, University of Washington, Seattle, Washington – sequence: 4 givenname: Francis M surname: Giardiello fullname: Giardiello, Francis M organization: Johns Hopkins University School of Medicine, Baltimore, Maryland – sequence: 5 givenname: David A surname: Johnson fullname: Johnson, David A organization: Eastern Virginia Medical School, Norfolk, Virginia – sequence: 6 givenname: Tonya surname: Kaltenbach fullname: Kaltenbach, Tonya organization: San Francisco Veterans Affairs Medical Center, San Francisco, California – sequence: 7 givenname: Theodore R surname: Levin fullname: Levin, Theodore R organization: Kaiser Permanente Medical Center, Walnut Creek, California – sequence: 8 givenname: David surname: Lieberman fullname: Lieberman, David organization: Oregon Health and Science University, Portland, Oregon – sequence: 9 givenname: Douglas J surname: Robertson fullname: Robertson, Douglas J organization: VA Medical Center, White River Junction, Vermont, and Geisel School of Medicine at Dartmouth, Hanover, New Hampshire |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28600072$$D View this record in MEDLINE/PubMed |
| BookMark | eNplUEtLw0AYXKRiH_oPRPboJXEf2Ty8SbAqVCy2PYfN5kubmuzW3c2hd3-4ASsInmaGGWZgpmikjQaErikJKRH8bh9upfPWhIzQJCQiJJSfoQkVLA0IoWz0h4_R1Lk9ISTjKb1AY5bGg0jYBH3lpjUWlJctzqVWYPFKWQDd6O09fgdlug50JX1jtMO1sXi5O7pGNXKQUld4OVigvcNzazrsd4A34SrEr33rm2BlVAP-iNfSfeC5sQqw0fjf5CU6r2Xr4OqEM7SZP67z52Dx9vSSPywCJXjsA8k4jURNuJIQ1XVclqCgohkVwJmISqIgo0lERCIkF6mghAnFKxklPIlTytkM3f70Hqz57MH5omucgraVGkzvCpqRNGIpj8kQvTlF-7KDqjjYppP2WPw-x74B50pz0A |
| CitedBy_id | crossref_primary_10_1080_14737140_2019_1565999 crossref_primary_10_1177_09691413211061118 crossref_primary_10_1007_s00384_022_04273_w crossref_primary_10_14309_ctg_0000000000000243 crossref_primary_10_1007_s10330_021_0516_6 crossref_primary_10_1186_s12876_021_01966_4 crossref_primary_10_1055_s_0041_1726079 crossref_primary_10_1140_epjs_s11734_024_01338_5 crossref_primary_10_3748_wjg_v27_i47_8103 crossref_primary_10_3390_app15179829 crossref_primary_10_1038_s41395_018_0106_8 crossref_primary_10_1038_s41571_020_00445_1 crossref_primary_10_1159_000487145 crossref_primary_10_1097_CM9_0000000000000990 crossref_primary_10_1016_j_cgh_2024_10_010 crossref_primary_10_1007_s10620_018_5129_x crossref_primary_10_1002_hep_30330 crossref_primary_10_1186_s13073_023_01163_w crossref_primary_10_1007_s00384_019_03338_7 crossref_primary_10_1016_j_cca_2020_05_048 crossref_primary_10_7326_M21_2748 crossref_primary_10_3748_wjg_v25_i4_447 crossref_primary_10_7759_cureus_29667 crossref_primary_10_1016_j_cgh_2021_04_027 crossref_primary_10_1001_jamanetworkopen_2023_6693 crossref_primary_10_1016_j_gie_2018_07_034 crossref_primary_10_7759_cureus_77619 crossref_primary_10_1016_j_bios_2025_117190 crossref_primary_10_3748_wjg_v24_i22_2327 crossref_primary_10_1001_jamanetworkopen_2018_6343 crossref_primary_10_1016_j_imu_2025_101654 crossref_primary_10_1007_s10620_020_06634_3 crossref_primary_10_3389_fonc_2022_966998 crossref_primary_10_1016_j_gie_2020_12_001 crossref_primary_10_1177_0969141319859608 crossref_primary_10_1016_j_cgh_2018_12_017 crossref_primary_10_3390_cancers16162883 crossref_primary_10_1016_j_cgh_2020_04_077 crossref_primary_10_1016_j_media_2023_102832 crossref_primary_10_1007_s40615_017_0418_1 crossref_primary_10_1155_2022_8211941 crossref_primary_10_3390_cells10030710 crossref_primary_10_37126_aige_v6_i3_108281 crossref_primary_10_1007_s12020_024_04099_2 crossref_primary_10_1515_jom_2022_0167 crossref_primary_10_1055_s_0041_1740481 crossref_primary_10_1007_s10620_021_07213_w crossref_primary_10_7759_cureus_76557 crossref_primary_10_1007_s11894_019_0678_5 crossref_primary_10_1016_j_ejim_2023_09_023 crossref_primary_10_1186_s13148_021_01076_8 crossref_primary_10_1016_j_cgh_2020_11_019 crossref_primary_10_3390_diagnostics9030099 crossref_primary_10_1188_21_CJON_423_429 crossref_primary_10_1016_j_jmoldx_2020_03_009 crossref_primary_10_1016_j_socscimed_2023_116397 crossref_primary_10_1007_s11938_019_00219_4 crossref_primary_10_1007_s10620_018_4984_9 crossref_primary_10_1007_s11894_020_00770_6 crossref_primary_10_1002_advs_201802115 crossref_primary_10_31146_1682_8658_ecg_205_9_140_146 crossref_primary_10_2196_58479 crossref_primary_10_1002_ijc_31862 crossref_primary_10_1007_s10620_020_06539_1 crossref_primary_10_1007_s11938_020_00274_2 crossref_primary_10_1016_j_cgh_2020_11_003 crossref_primary_10_3892_mco_2022_2490 crossref_primary_10_3390_diagnostics13071262 crossref_primary_10_1097_MD_0000000000043222 crossref_primary_10_1001_jamanetworkopen_2021_22581 crossref_primary_10_7326_AITC202404160 crossref_primary_10_1053_j_gastro_2019_07_052 crossref_primary_10_1080_17474124_2021_1876561 crossref_primary_10_1177_0272989X21998980 crossref_primary_10_1007_s11606_020_06464_z crossref_primary_10_1007_s00464_025_11890_3 crossref_primary_10_1007_s11606_019_05399_4 crossref_primary_10_1007_s10151_019_1926_2 crossref_primary_10_1038_s41395_018_0180_y crossref_primary_10_14309_ctg_0000000000000458 crossref_primary_10_14309_ctg_0000000000000694 crossref_primary_10_1093_jnci_djab044 crossref_primary_10_1016_j_bspc_2023_105792 crossref_primary_10_1158_1940_6207_CAPR_21_0075 crossref_primary_10_3390_cancers10120472 crossref_primary_10_1093_jleuko_qiae084 crossref_primary_10_1177_17588359241229434 crossref_primary_10_1007_s10620_020_06242_1 crossref_primary_10_4251_wjgo_v13_i8_856 crossref_primary_10_1016_j_cgh_2021_04_034 crossref_primary_10_1007_s11605_020_04663_x crossref_primary_10_1177_10732748251313499 crossref_primary_10_1186_s12916_022_02416_y crossref_primary_10_1093_milmed_usaa319 crossref_primary_10_1109_JBHI_2022_3173948 crossref_primary_10_3390_cancers13184640 crossref_primary_10_1001_jamainternmed_2023_0435 crossref_primary_10_1053_j_gastro_2024_12_030 crossref_primary_10_1097_MD_0000000000025933 crossref_primary_10_1007_s10620_020_06167_9 crossref_primary_10_1002_jcla_24637 crossref_primary_10_1111_jgh_15040 crossref_primary_10_1007_s10620_019_05956_1 crossref_primary_10_1186_s13148_022_01302_x crossref_primary_10_3390_diagnostics13182939 crossref_primary_10_7759_cureus_20506 crossref_primary_10_1038_s41416_018_0264_x crossref_primary_10_1007_s10903_021_01291_8 crossref_primary_10_1007_s13193_022_01496_9 crossref_primary_10_1007_s10620_025_08889_0 crossref_primary_10_1159_000526606 crossref_primary_10_14309_ajg_0000000000002193 crossref_primary_10_1080_1758194X_2025_2494439 crossref_primary_10_1001_jamanetworkopen_2021_12539 crossref_primary_10_1111_codi_15819 crossref_primary_10_14309_ajg_0000000000003287 crossref_primary_10_7326_M22_1139 crossref_primary_10_1097_SGA_0000000000000515 crossref_primary_10_4251_wjgo_v16_i8_3393 crossref_primary_10_1111_ans_18357 crossref_primary_10_1016_j_gastre_2019_01_015 crossref_primary_10_14309_ajg_0000000000001884 crossref_primary_10_1016_j_mcna_2018_08_010 crossref_primary_10_1002_jso_27299 crossref_primary_10_1007_s11888_021_00465_8 crossref_primary_10_14423_SMJ_0000000000001163 crossref_primary_10_1093_jnci_djaa164 crossref_primary_10_1097_MCG_0000000000001540 crossref_primary_10_1055_a_1817_3925 crossref_primary_10_1016_j_rcl_2018_04_007 crossref_primary_10_2147_CLEP_S362362 crossref_primary_10_1053_j_gastro_2018_01_069 crossref_primary_10_3389_fonc_2025_1575844 crossref_primary_10_3322_caac_21457 crossref_primary_10_1080_14737140_2017_1392243 crossref_primary_10_1053_j_gastro_2022_05_011 crossref_primary_10_1007_s12029_024_01041_7 crossref_primary_10_1186_s12885_025_14152_6 crossref_primary_10_1109_TIM_2020_3038011 crossref_primary_10_1371_journal_pone_0244431 crossref_primary_10_1002_cam4_3488 crossref_primary_10_1007_s12664_020_01066_3 crossref_primary_10_1001_jamanetworkopen_2023_39670 crossref_primary_10_1186_s13053_020_00164_9 crossref_primary_10_3322_caac_21446 crossref_primary_10_1016_j_dld_2022_06_002 crossref_primary_10_1016_j_cgh_2021_02_028 crossref_primary_10_1089_pop_2020_0076 crossref_primary_10_1016_j_gtc_2022_05_002 crossref_primary_10_1136_bmjoq_2022_001927 crossref_primary_10_1038_s41598_019_54385_7 crossref_primary_10_1016_j_clcc_2023_02_001 crossref_primary_10_1093_jnci_djac003 crossref_primary_10_1158_1940_6207_CAPR_22_0506 crossref_primary_10_1016_j_cgh_2021_09_010 crossref_primary_10_1016_j_ejso_2021_10_021 crossref_primary_10_3390_diagnostics13243673 crossref_primary_10_3390_diagnostics11122264 crossref_primary_10_1158_1940_6207_CAPR_25_0007 crossref_primary_10_1053_j_gastro_2018_12_012 crossref_primary_10_3322_caac_21557 crossref_primary_10_1159_000493336 crossref_primary_10_12998_wjcc_v9_i15_3607 crossref_primary_10_3322_caac_21550 crossref_primary_10_3390_diagnostics11122393 crossref_primary_10_1016_j_jclinepi_2025_111669 crossref_primary_10_1111_nmo_13890 crossref_primary_10_1016_j_cca_2018_04_021 crossref_primary_10_1002_cac2_12499 crossref_primary_10_1097_CEJ_0000000000000488 crossref_primary_10_1007_s13631_018_0175_0 crossref_primary_10_1016_j_cgh_2023_03_017 crossref_primary_10_3390_diagnostics14181999 crossref_primary_10_3390_medicina60040673 crossref_primary_10_3390_cells10051018 crossref_primary_10_1016_j_canep_2022_102267 crossref_primary_10_1053_j_gastro_2021_05_063 crossref_primary_10_1016_j_ejim_2021_02_003 crossref_primary_10_29333_ejgm_16745 crossref_primary_10_1007_s00117_025_01453_x crossref_primary_10_1016_j_aej_2025_05_045 crossref_primary_10_1053_j_gastro_2018_08_019 crossref_primary_10_14309_ajg_0000000000000639 crossref_primary_10_1007_s00384_021_03894_x crossref_primary_10_1016_S2468_1253_21_00426_X crossref_primary_10_1053_j_gastro_2018_08_017 crossref_primary_10_1158_2159_8290_CD_22_1038 crossref_primary_10_3389_fendo_2022_924952 crossref_primary_10_1111_1751_2980_13027 crossref_primary_10_7759_cureus_14382 crossref_primary_10_3892_mco_2023_2706 crossref_primary_10_3389_fonc_2020_621295 crossref_primary_10_1053_j_gastro_2021_02_015 crossref_primary_10_1155_2021_1171239 crossref_primary_10_1186_s43058_021_00221_x crossref_primary_10_3390_ijerph19053071 crossref_primary_10_1002_deo2_70141 crossref_primary_10_7326_M18_3633 crossref_primary_10_1016_j_jbi_2023_104568 crossref_primary_10_1007_s11606_021_07263_w crossref_primary_10_1053_j_gastro_2023_12_027 crossref_primary_10_1007_s10620_025_09195_5 crossref_primary_10_1016_j_clcc_2018_02_012 crossref_primary_10_1053_j_gastro_2023_06_033 crossref_primary_10_5604_01_3001_0054_6995 crossref_primary_10_1016_j_gie_2018_12_021 crossref_primary_10_1097_MEG_0000000000002259 crossref_primary_10_23736_S1121_421X_19_02609_6 crossref_primary_10_1109_JSEN_2025_3553904 crossref_primary_10_37699_2308_7005_1_2025_02 crossref_primary_10_1016_j_cgh_2018_05_022 crossref_primary_10_1016_j_giec_2024_10_005 crossref_primary_10_1056_NEJMc2404924 crossref_primary_10_1001_jamanetworkopen_2023_21730 crossref_primary_10_1016_j_gastrohep_2019_01_010 crossref_primary_10_1053_j_gastro_2019_09_004 crossref_primary_10_1001_jamanetworkopen_2019_20407 crossref_primary_10_3748_wjg_v25_i21_2565 crossref_primary_10_4166_kjg_2024_146 crossref_primary_10_1053_j_gastro_2022_05_036 crossref_primary_10_1007_s10620_019_05991_y crossref_primary_10_1186_s13148_022_01328_1 crossref_primary_10_1097_MCG_0000000000001894 crossref_primary_10_1097_NCC_0000000000001467 crossref_primary_10_1002_ijc_34648 crossref_primary_10_7475_kjan_2021_33_6_545 crossref_primary_10_1038_s41575_019_0189_8 crossref_primary_10_1053_j_gastro_2018_08_040 crossref_primary_10_1016_j_giec_2021_08_001 crossref_primary_10_1016_j_ejim_2021_02_008 crossref_primary_10_1007_s11633_023_1380_5 crossref_primary_10_1016_j_mayocp_2019_12_016 crossref_primary_10_1053_j_gastro_2020_03_086 crossref_primary_10_3390_jcm14186583 crossref_primary_10_1007_s12094_020_02302_0 crossref_primary_10_1109_TETCI_2022_3193677 crossref_primary_10_1016_j_jaip_2020_12_054 crossref_primary_10_1055_a_1995_2685 crossref_primary_10_1136_gutjnl_2020_321698 crossref_primary_10_1038_s41598_024_82415_6 crossref_primary_10_1007_s00464_020_07607_3 crossref_primary_10_1093_ehjopen_oeae081 crossref_primary_10_1177_09691413231174163 crossref_primary_10_1089_ars_2020_8244 crossref_primary_10_1007_s10620_019_05808_y crossref_primary_10_1016_j_bios_2025_117506 crossref_primary_10_1016_j_cct_2021_106430 crossref_primary_10_1097_MEG_0000000000002209 crossref_primary_10_1016_j_cgh_2019_11_044 crossref_primary_10_1016_j_snb_2023_134482 crossref_primary_10_1007_s10620_018_5001_z crossref_primary_10_31146_1682_8658_ecg_212_4_19_27 crossref_primary_10_3892_ol_2025_15068 crossref_primary_10_7326_M19_2477 crossref_primary_10_1111_jgh_15701 crossref_primary_10_1016_j_gie_2025_02_010 crossref_primary_10_2147_CMAR_S297596 crossref_primary_10_14309_ajg_0000000000002693 crossref_primary_10_1089_gtmb_2018_0332 crossref_primary_10_1111_jgh_14851 crossref_primary_10_3389_fonc_2025_1533475 crossref_primary_10_1016_j_bpg_2022_101798 crossref_primary_10_1155_2020_7246570 crossref_primary_10_1016_j_gie_2020_09_044 crossref_primary_10_3390_diagnostics15030368 crossref_primary_10_1053_j_gastro_2018_09_040 crossref_primary_10_1016_j_cgh_2019_03_017 crossref_primary_10_1016_j_heliyon_2025_e41836 crossref_primary_10_1186_s12871_020_01141_4 crossref_primary_10_1089_whr_2022_0014 crossref_primary_10_1007_s10620_019_05882_2 crossref_primary_10_1111_den_14627 crossref_primary_10_3748_wjg_v26_i37_5705 crossref_primary_10_1111_jgs_18412 crossref_primary_10_3389_fonc_2021_734998 crossref_primary_10_1148_radiol_2021202363 crossref_primary_10_1053_j_gastro_2019_12_015 crossref_primary_10_14309_ajg_0000000000000261 crossref_primary_10_1186_s12885_022_10047_y crossref_primary_10_1053_j_gastro_2019_12_012 crossref_primary_10_1053_j_gastro_2020_07_011 crossref_primary_10_1093_ibd_izaa205 crossref_primary_10_1002_cam4_2216 crossref_primary_10_1007_s10552_023_01795_8 crossref_primary_10_1016_j_amjcard_2021_07_049 crossref_primary_10_1016_j_gie_2022_04_1343 crossref_primary_10_1111_den_13769 crossref_primary_10_1053_j_gastro_2021_10_017 crossref_primary_10_1038_s41598_018_28671_9 crossref_primary_10_1158_1940_6207_CAPR_22_0238 crossref_primary_10_1053_j_gastro_2019_05_071 crossref_primary_10_1111_jgh_15924 crossref_primary_10_3389_fonc_2024_1325514 crossref_primary_10_1007_s10916_020_01604_8 crossref_primary_10_1001_jamanetworkopen_2023_13367 crossref_primary_10_1371_journal_pone_0240445 crossref_primary_10_1002_gepi_22338 crossref_primary_10_1097_MEG_0000000000001205 crossref_primary_10_1016_j_gie_2018_09_006 crossref_primary_10_1053_j_gastro_2017_08_018 crossref_primary_10_1016_j_gie_2025_02_039 crossref_primary_10_1007_s00384_021_03897_8 crossref_primary_10_1053_j_gastro_2021_10_007 crossref_primary_10_1016_j_cgh_2018_07_002 crossref_primary_10_1002_ijc_34455 crossref_primary_10_3390_cells13161314 crossref_primary_10_3748_wjg_v26_i16_1962 crossref_primary_10_14309_ajg_0000000000001572 crossref_primary_10_1007_s11606_022_07555_9 crossref_primary_10_1053_j_gastro_2023_03_206 crossref_primary_10_14309_ajg_0000000000000467 crossref_primary_10_1053_j_gastro_2025_02_002 crossref_primary_10_1186_s12885_022_10418_5 crossref_primary_10_1097_MCG_0000000000001594 crossref_primary_10_1097_MCG_0000000000001115 crossref_primary_10_1007_s11606_018_4648_7 crossref_primary_10_1038_s41395_018_0187_4 crossref_primary_10_1007_s13187_024_02479_w crossref_primary_10_1007_s00384_020_03672_1 crossref_primary_10_1053_j_gastro_2019_03_023 crossref_primary_10_1001_jamanetworkopen_2020_3398 crossref_primary_10_14309_ajg_0000000000001548 crossref_primary_10_1007_s00330_025_11371_0 crossref_primary_10_1007_s10620_025_09372_6 crossref_primary_10_1016_j_amjmed_2021_08_004 crossref_primary_10_1016_j_giec_2021_12_010 crossref_primary_10_1007_s10552_021_01408_2 crossref_primary_10_1016_j_giec_2021_12_012 crossref_primary_10_1186_s12876_019_1127_5 crossref_primary_10_4253_wjge_v13_i12_638 crossref_primary_10_1097_DCR_0000000000002022 crossref_primary_10_1016_j_dld_2020_05_017 crossref_primary_10_1200_EDBK_200961 crossref_primary_10_1016_j_cancergen_2017_11_001 crossref_primary_10_1016_j_cgh_2018_08_023 crossref_primary_10_1093_fampra_cmaa043 crossref_primary_10_1016_j_scrs_2021_100845 crossref_primary_10_1016_j_bpg_2025_102014 crossref_primary_10_14309_ajg_0000000000001531 crossref_primary_10_1016_j_cgh_2019_09_007 crossref_primary_10_2147_RMHP_S359450 crossref_primary_10_1007_s11606_023_08439_2 crossref_primary_10_1053_j_gastro_2019_02_001 crossref_primary_10_1016_j_giec_2021_12_001 crossref_primary_10_1109_TMI_2024_3459910 crossref_primary_10_1177_2050640619888040 crossref_primary_10_1136_bmj_n877 crossref_primary_10_1038_s41395_018_0406_z crossref_primary_10_1097_DCR_0000000000002130 crossref_primary_10_1016_j_bspc_2022_103846 crossref_primary_10_1016_j_giec_2021_12_009 crossref_primary_10_1038_s41575_023_00847_3 crossref_primary_10_1038_s41598_021_97163_0 crossref_primary_10_1016_j_gie_2019_12_027 crossref_primary_10_7759_cureus_48740 crossref_primary_10_1038_s41571_025_01037_7 crossref_primary_10_1007_s00330_021_08532_2 crossref_primary_10_1007_s00268_019_05310_6 crossref_primary_10_3390_jcm12031032 crossref_primary_10_1186_s13148_020_00954_x crossref_primary_10_1080_17474124_2023_2273990 crossref_primary_10_1007_s00384_018_3182_8 crossref_primary_10_1053_j_gastro_2017_09_026 crossref_primary_10_1007_s11894_018_0618_9 crossref_primary_10_7759_cureus_36917 crossref_primary_10_1007_s11760_023_02835_1 crossref_primary_10_1016_j_cgh_2022_12_008 crossref_primary_10_1001_jamanetworkopen_2023_31155 crossref_primary_10_1111_ecc_13577 crossref_primary_10_3390_ijms25042032 crossref_primary_10_1016_j_cgh_2024_01_033 crossref_primary_10_1055_a_2556_1836 crossref_primary_10_1053_j_gastro_2019_06_043 crossref_primary_10_1007_s00464_019_07226_7 crossref_primary_10_1016_j_soc_2021_11_006 crossref_primary_10_1093_jcag_gwad017 crossref_primary_10_7326_ANNALS_24_03144 crossref_primary_10_1097_DCR_0000000000001062 crossref_primary_10_1016_j_gie_2021_05_034 crossref_primary_10_1038_s41598_024_76951_4 crossref_primary_10_1186_s12911_022_01872_z crossref_primary_10_1002_cam4_3811 crossref_primary_10_1053_j_gastro_2021_06_006 crossref_primary_10_1053_j_gastro_2022_08_011 crossref_primary_10_1097_NCC_0000000000000985 crossref_primary_10_1016_j_giec_2020_03_001 crossref_primary_10_1371_journal_pcbi_1007552 crossref_primary_10_1001_jamanetworkopen_2022_22131 crossref_primary_10_1002_cncr_31660 crossref_primary_10_1007_s11894_019_0674_9 crossref_primary_10_1053_j_sult_2022_03_004 crossref_primary_10_1155_2022_9338139 crossref_primary_10_1002_cncr_31542 crossref_primary_10_1002_ptr_6626 crossref_primary_10_1016_j_jss_2019_07_004 crossref_primary_10_1097_DCR_0000000000002069 crossref_primary_10_1097_MD_0000000000029259 crossref_primary_10_1159_000516962 crossref_primary_10_1002_cld_923 crossref_primary_10_1053_j_gastro_2019_10_029 crossref_primary_10_3389_fmed_2019_00245 crossref_primary_10_1111_jgh_15529 crossref_primary_10_3390_diagnostics12030610 crossref_primary_10_1016_j_amjcard_2018_11_046 crossref_primary_10_1016_j_scrs_2024_101037 crossref_primary_10_5888_pcd19_210315 crossref_primary_10_1053_j_gastro_2019_10_030 crossref_primary_10_1186_s12957_020_02049_6 crossref_primary_10_1016_j_cgh_2022_07_028 crossref_primary_10_7326_M22_0301 crossref_primary_10_1136_gutjnl_2023_329429 crossref_primary_10_1016_j_pec_2018_11_010 crossref_primary_10_1080_17474124_2023_2212159 crossref_primary_10_3389_fonc_2023_1072259 crossref_primary_10_1056_NEJMoa2304714 crossref_primary_10_1007_s00520_022_06794_0 crossref_primary_10_1016_j_gie_2018_02_024 crossref_primary_10_7326_M19_0301 crossref_primary_10_3892_ol_2024_14594 crossref_primary_10_1007_s10620_019_05644_0 crossref_primary_10_1002_14651858_CD015476_pub2 crossref_primary_10_1200_EDBK_279901 crossref_primary_10_1146_annurev_med_103018_123125 crossref_primary_10_1016_j_dld_2024_11_001 crossref_primary_10_1016_j_lfs_2024_122711 crossref_primary_10_1007_s12664_020_01060_9 crossref_primary_10_3389_fimmu_2022_967921 crossref_primary_10_1016_j_media_2021_102180 crossref_primary_10_1177_23743735231213765 crossref_primary_10_1097_CM9_0000000000003253 crossref_primary_10_1016_j_mayocp_2019_02_021 crossref_primary_10_2174_0115748863301630240417071353 crossref_primary_10_1097_SGA_0000000000000591 crossref_primary_10_1002_ijc_31920 crossref_primary_10_3390_healthcare12141448 crossref_primary_10_1055_s_0041_1740275 crossref_primary_10_1002_cam4_7136 crossref_primary_10_2217_crc_2017_0007 crossref_primary_10_2174_0929867327666200427094054 crossref_primary_10_2217_crc_2020_0019 crossref_primary_10_1016_j_giec_2020_02_008 crossref_primary_10_1016_j_tige_2023_02_004 crossref_primary_10_1007_s11606_021_07368_2 crossref_primary_10_1016_j_giec_2020_02_002 crossref_primary_10_1080_00365521_2024_2356649 crossref_primary_10_1016_j_giec_2020_02_003 crossref_primary_10_2217_crc_2020_0012 crossref_primary_10_1016_j_cdtm_2018_08_004 crossref_primary_10_7326_M24_0743 crossref_primary_10_4251_wjgo_v17_i4_104253 crossref_primary_10_1177_10732748251341524 crossref_primary_10_1016_j_clinimag_2025_110401 crossref_primary_10_1016_j_giec_2020_02_005 crossref_primary_10_1097_MCG_0000000000002183 crossref_primary_10_1097_MLR_0000000000001186 crossref_primary_10_7759_cureus_33424 crossref_primary_10_1016_j_ypmed_2024_108137 crossref_primary_10_1001_jamanetworkopen_2025_23450 crossref_primary_10_1038_s41598_021_03225_8 crossref_primary_10_12998_wjcc_v9_i10_2238 crossref_primary_10_14309_ajg_0000000000001018 crossref_primary_10_1097_MCG_0000000000001099 crossref_primary_10_1080_10408363_2019_1670614 crossref_primary_10_1053_j_gastro_2023_02_021 crossref_primary_10_1053_j_gastro_2020_12_029 crossref_primary_10_1186_s12885_017_3873_5 crossref_primary_10_1007_s11377_024_00812_9 crossref_primary_10_1053_j_gastro_2021_09_075 crossref_primary_10_1007_s43472_025_00159_8 crossref_primary_10_3390_biology14070805 crossref_primary_10_14309_ajg_0000000000001020 crossref_primary_10_1016_j_gie_2021_06_012 crossref_primary_10_1186_s12876_025_03828_9 crossref_primary_10_1016_j_giec_2020_02_012 crossref_primary_10_14309_ajg_0000000000001265 crossref_primary_10_3390_ijerph19052676 crossref_primary_10_1016_j_giec_2020_02_015 crossref_primary_10_14309_ajg_0000000000001143 |
| ContentType | Journal Article |
| Copyright | Copyright © 2017 AGA Institute, American College of Gastroenterology, and the American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2017 AGA Institute, American College of Gastroenterology, and the American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1053/j.gastro.2017.05.013 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1528-0012 |
| ExternalDocumentID | 28600072 |
| Genre | Journal Article Practice Guideline |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 1B1 1CY 1P~ 1~5 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 AAEDT AAEDW AAFWJ AAIKJ AALRI AAQFI AAQOH AAQQT AAQXK AAXUO ABCQX ABDPE ABJNI ABLJU ABMAC ABOCM ABWVN ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO AENEX AEVXI AFCTW AFFNX AFHKK AFJKZ AFRHN AFTJW AGCQF AGHFR AGQPQ AI. AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BELOY BR6 C5W CAG CGR COF CS3 CUY CVF DU5 EBS ECM EFJIC EFKBS EIF EJD F5P FD8 FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N4W N9A NPM NQ- O9- OC. OHT ON0 P2P PC. QTD R2- RIG ROL RPZ SEL SES SJN SSZ UDS UGJ UV1 VH1 WH7 X7M XH2 Y6R YQJ Z5R ZGI ZXP 7X8 |
| ID | FETCH-LOGICAL-c536t-a23145f03cae4ff6bbeced1915e3254b0ce91740575a35851025c3da473768132 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 105 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000403918300044&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1528-0012 |
| IngestDate | Sat Sep 27 22:09:34 EDT 2025 Mon Jul 21 05:56:12 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Copyright © 2017 AGA Institute, American College of Gastroenterology, and the American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c536t-a23145f03cae4ff6bbeced1915e3254b0ce91740575a35851025c3da473768132 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Instructional Material/Guideline-3 content type line 23 |
| PMID | 28600072 |
| PQID | 1908428360 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1908428360 pubmed_primary_28600072 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-07-01 |
| PublicationDateYYYYMMDD | 2017-07-01 |
| PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Gastroenterology (New York, N.Y. 1943) |
| PublicationTitleAlternate | Gastroenterology |
| PublicationYear | 2017 |
| SSID | ssj0009381 |
| Score | 2.648755 |
| Snippet | This document updates the colorectal cancer (CRC) screening recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 307 |
| SubjectTerms | Adenoma - diagnosis Adenoma - genetics Age Factors Colonography, Computed Tomographic Colonoscopy Colorectal Neoplasms - diagnosis Colorectal Neoplasms - genetics DNA - analysis Early Detection of Cancer - standards Feces - chemistry Humans Occult Blood Population Surveillance Risk Factors Septins - blood Sigmoidoscopy United States |
| Title | Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28600072 https://www.proquest.com/docview/1908428360 |
| Volume | 153 |
| WOSCitedRecordID | wos000403918300044&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvCaNu3msfEiUgwebAm0hd7CZncjKk1qUv0F_nBnkg09iCB4ySkhITv7zTc7M98QcsMZEmOVWJ7HIUCRXMGWspXFggScGfdTW1eS-U_-aMRnsyAyB26lKatsMLECapVLPCPvguPiKA7m2XeLdwunRmF21YzQWCctBlQGrdqfrdTCA8ZrvVRUYQYkblrnXNZ97TyLcllg-1_PaHey30lm5WzC3f9-5h7ZMTST3td2sU_WdHZAtoYmkX5IvgYAegh2cNMAF76gY4klOODJbinGpPO5NvOWSgrElkbNEUhJRaZoVOuxljQs8jkFFkmnnXGHVv28likFpRNRvtEwL6SmeUZ_vPKITMOHyeDRMgMZLOkyb2kJIIOOm9pMCu2kqZeAAWgFEZ-rGQSaiS01RH8VBRQM841AqCRTwvEBxjjEvcdkI8szfUooNujaytaSO9wBHBGOcLXvgIV4QdJL_Da5bv5vDAaPWQyR6fyjjFd_uE1O6kWKF7UyR9znHpKe_tkfnj4n27j2dentBWmlsN31JdmUn8uXsriqLAmuo2j4DVJr0bk |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Colorectal+Cancer+Screening%3A+Recommendations+for+Physicians+and+Patients+From+the+U.S.+Multi-Society+Task+Force+on+Colorectal+Cancer&rft.jtitle=Gastroenterology+%28New+York%2C+N.Y.+1943%29&rft.au=Rex%2C+Douglas+K&rft.au=Boland%2C+C+Richard&rft.au=Dominitz%2C+Jason+A&rft.au=Giardiello%2C+Francis+M&rft.date=2017-07-01&rft.eissn=1528-0012&rft.volume=153&rft.issue=1&rft.spage=307&rft_id=info:doi/10.1053%2Fj.gastro.2017.05.013&rft_id=info%3Apmid%2F28600072&rft_id=info%3Apmid%2F28600072&rft.externalDocID=28600072 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-0012&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-0012&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-0012&client=summon |